BChE-IN-5 is a potent and selective butyrylcholinesterase (BChE) inhibitor with an IC50 value of 2.8 nM against human BChE (hBChE), showing greater selectivity for hBChE over human acetylcholinesterase (hAChE); it has potential for the research of Alzheimer's disease.